Asia-Pacific Americas Africa Europe Middle East

NOVELFARMA ILAC SANAYI

Company Profile:

Company Type: Manufacturer

Company Introduction:

NOVELFARMA ILAC SANAYI A.S. is a pharmaceutical company based in Istanbul, Turkey. The company specializes in the research, development, production, and marketing of a diverse portfolio of pharmaceutical products. Operating with its own state-of-the-art manufacturing facilities, NOVELFARMA is committed to delivering high-quality, effective, and innovative medicinal solutions to both domestic and international markets, adhering to international pharmaceutical industry standards.

Enterprise Products

Company: NOVELFARMA ILAC SANAYI (Turkey)

Products manufactured or sold by NOVELFARMA ILAC SANAYI include a range of pharmaceutical products across various therapeutic areas. Some of their key product categories and examples of medicines within them are:

Cardiology:

Lisinopril + Hydrochlorothiazide (Lisinor)

Valsartan + Hydrochlorothiazide (Valpres Plus)

Amlodipine (Amlor)

Rosuvastatin (Rosvel)

Clopidogrel (Clopivel)

Central Nervous System:

Pregabalin (Pregavel)

Gabapentin (Gabatin)

Donepezil (Donewell)

Memantine (Memantivel)

Urology:

Tamsulosin (Tamsulvel)

Solifenacin (Solifenasin)

Gastroenterology:

Pantoprazole (Pantovel)

Esomeprazole (Esomvel)

Metoclopramide (Metovel)

Infectious Diseases:

Levofloxacin (Levovel)

Moxifloxacin (Moxivel)

Pain and Inflammation:

Etodolac (Etovel)

Dexketoprofen (Deksketovel)

Oncology:

Letrozole (Letrovel)

Anastrozole (Anastrovel)

Metabolic Diseases:

Metformin (Metvel)

Vildagliptin (Vildavel)

Respiratory System:

Montelukast (Montelvel)

Dermatology:

Mometasone (Mometavel)

Business Registration Information:

Manager:

Dr. Ecz. Hasan Gokhan AYIK (Chairman of the Board)

Phone:

+90 212 284 40 40

E-mail:

info@novelfarma.com.tr

Official Website:
Address:

Esentepe Mah. Buyukdere Cad. No:199 Levent 199 Plaza Kat:14 Ofis No:57 Sisli / Istanbul / Turkey

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.